Trimethoprim-sulfamethoxazole. Metabolism of folic acid in man.
D000380:Agranulocytosis / Q000139:chemically induced; D062365:Aminobenzoates / Q000378:metabolism; D000740:Anemia / Q000139:chemically induced; D001646:Bile / Q000378:metabolism; D001693:Biological Transport, Active / Q000187:drug effects; D001853:Bone Marrow / Q000378:metabolism; D001854:Bone Marrow Cells; D004247:DNA / Q000096:biosynthesis; D003864:Depression, Chemical; D005260:Female; D005492:Folic Acid / Q000378:metabolism* / Q000652:urine; D005493:Folic Acid Antagonists; D005502:Food; D006801:Humans; D007408:Intestinal Absorption; D007970:Leukopenia / Q000139:chemically induced; D009504:Neutrophils; D011247:Pregnancy; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000494:pharmacology*; D013449:Sulfonamides / Q000009:adverse effects; D013763:Tetrahydrofolates / Q000378:metabolism; D013921:Thrombocytopenia / Q000139:chemically induced; D014295:Trimethoprim / Q000009:adverse effects / Q000494:pharmacology*
D062365:Aminobenzoates; D005493:Folic Acid Antagonists; D013449:Sulfonamides; D013763:Tetrahydrofolates; D004247:DNA; D005492:Folic Acid; D014295:Trimethoprim; D013420:Sulfamethoxazole